For more information or confidential assistance
800-306-3180
se habla español

Zofran Lawsuits Consolidated Under Multidistrict Litigation

The U.S. Judicial Panel on Multidistrict Litigation (JPML) issued a transfer order on October 13, 2015 to centralize all federal Zofran claims into a multidistrict litigation (MDL). The MDL is pending in the U.S. District Court for the District of Massachusetts, where it is proceeding under the direction of Judge F.... Read more »

California Parents File Zofran Lawsuit Against GSK

A Northern California couple has filed a Zofran lawsuit against GlaxoSmithKline on behalf of their young daughter. The parents seek compensatory and punitive damages, equitable relief and other relief deemed appropriate for the injuries their child sustained as an alleged result of her mother’s use of Zofran during pregnancy. The... Read more »

Kentucky Plaintiffs Blame Zofran for Newborn Death

A Kentucky couple has filed a Zofran lawsuit against manufacturer GlaxoSmithKline, LLC (GSK) over the death of their son. The lawsuit also names Hospira, Inc., and Pfizer, Inc., makers of the generic form of the drug, as defendants. The lawsuit was filed on September 30, 2015, in the United States... Read more »

FDA Requests That Pfizer Update Zoloft Label

The U.S. Food and Drug Administration has asked Pfizer to update its Zoloft safety warnings to acknowledge that some studies have linked the antidepressant to infant heart defects. There is still no concrete evidence definitively connecting the drug to birth defects, but some researchers have noted an “increased risk of... Read more »

New Zofran Lawsuit Alleges Heart Abnormalities Due to Drug

Adding to the growing docket of Zofran birth defect lawsuits is a new complaint filed in the United States District Court for the Northern District of California by a mother who alleges that her young daughter’s heart malformations and resulting health difficulties are attributable to exposure to the anti-nausea drug... Read more »